Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
{{output}}
Background: Approximately 2-3% of patients undergoing advanced heart failure therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have chemotherapy-related cardiomyopathy, according... ...
